Indian vaccine maker Bharat Biotech is seeking international manufacturing partners as it targets a billion doses of its COVID-19 vaccine each year, the company said on Sunday.

India’s Bharat Biotech said on Friday it was slowing down the production of COVID-19 vaccine Covaxin, as demand was dropping along with a fall in infections and wider immunisation coverage in ...

Covaxin, which was widely used as a Covid vaccine, was jointly developed by the Indian Council of Medical Research (ICMR), National Institute of Virology, and Bharat Biotech International Ltd.

Jan 9 (Reuters) - Ocugen Inc (OCGN.O) said on Monday the COVID-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States.

Soon enough, on September 13, Bharat Biotech International filed a defamation suit of Rs 5 crore on the research team. It must be noted that ICMR and Bharat Biotech produced Covaxin jointly.

No articles found. Bharat Biotech International Limited did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The Nature Index 2025 Research ...

About Bharat Biotech International Limited Bharat Biotech International Limited, Hyderabad, India, is a multidimensional biotech-nology company specializing in product-oriented research ...